aluates Reports

$ 0.0

Automative

Global Age-related Macular Degeneration Drugs Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-26W8483

Global Age Related Macular Degeneration Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Age-related Macular Degeneration Drugs Market Research Report 2025

Code: QYRE-Auto-26W8483

Report

March 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Regeneron Pharmaceuticals

Roche Holding

Bayer

Biogen

Alimera Sciences

Adverum Biotechnologies

Eyepoint Pharmaceuticals

Outlook Therapeutics

Apellis Pharmaceuticals

Amgen Inc

Age-related Macular Degeneration Drugs Market Size

The global market for Age-related Macular Degeneration Drugs was valued at US$ 8657 million in the year 2024 and is projected to reach a revised size of US$ 11500 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Age-related Macular Degeneration Drugs Market

Age-related macular degeneration (AMD) drugs refer to drugs used to treat age-related macular degeneration. These drugs are designed to slow or prevent the progression of AMD by inhibiting the formation of new blood vessels, reducing inflammatory responses, and providing antioxidant protection, thereby protecting the patient's vision.

In recent years, with the intensification of the global aging trend and the improvement of people's awareness of eye health, the market size of age-related macular degeneration drugs has continued to expand. From a regional perspective, North America and Europe are the main markets for age-related macular degeneration drugs, each occupying a large market share. Emerging markets such as China are also growing rapidly and are expected to become an important part of the global age-related macular degeneration drug market in the future.

This report aims to provide a comprehensive presentation of the global market for Age-related Macular Degeneration Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age-related Macular Degeneration Drugs.

The Age-related Macular Degeneration Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Age-related Macular Degeneration Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Age-related Macular Degeneration Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Age-related Macular Degeneration Drugs Market Report

Report Metric	Details
Report Name	Age-related Macular Degeneration Drugs Market
Accounted market size in year	US$ 8657 million
Forecasted market size in 2031	US$ 11500 million
CAGR	4.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antioxidants Anti-inflammatory Drugs Others
Segment by Application	Wet AMD Treatment Adjunctive Treatment of Dry AMD Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Regeneron Pharmaceuticals, Roche Holding, Novartis, Bayer, Biogen, Alimera Sciences, Adverum Biotechnologies, Eyepoint Pharmaceuticals, Outlook Therapeutics, Apellis Pharmaceuticals, Amgen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age-related Macular Degeneration Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Age-related Macular Degeneration Drugs Market growing?

Ans: The Age-related Macular Degeneration Drugs Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Age-related Macular Degeneration Drugs Market size in 2031?

Ans: The Age-related Macular Degeneration Drugs Market size in 2031 will be US$ 11500 million.

Who are the main players in the Age-related Macular Degeneration Drugs Market report?

Ans: The main players in the Age-related Macular Degeneration Drugs Market are Regeneron Pharmaceuticals, Roche Holding, Novartis, Bayer, Biogen, Alimera Sciences, Adverum Biotechnologies, Eyepoint Pharmaceuticals, Outlook Therapeutics, Apellis Pharmaceuticals, Amgen

What are the Application segmentation covered in the Age-related Macular Degeneration Drugs Market report?

Ans: The Applications covered in the Age-related Macular Degeneration Drugs Market report are Wet AMD Treatment, Adjunctive Treatment of Dry AMD, Others

What are the Type segmentation covered in the Age-related Macular Degeneration Drugs Market report?

Ans: The Types covered in the Age-related Macular Degeneration Drugs Market report are Antioxidants, Anti-inflammatory Drugs, Others

Recommended Reports

Ophthalmology Drugs

Eye Disease Treatments

Macular Degeneration Related

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Age-related Macular Degeneration Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antioxidants

1.2.3 Anti-inflammatory Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Age-related Macular Degeneration Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Wet AMD Treatment

1.3.3 Adjunctive Treatment of Dry AMD

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Age-related Macular Degeneration Drugs Market Perspective (2020-2031)

2.2 Global Age-related Macular Degeneration Drugs Growth Trends by Region

2.2.1 Global Age-related Macular Degeneration Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Age-related Macular Degeneration Drugs Historic Market Size by Region (2020-2025)

2.2.3 Age-related Macular Degeneration Drugs Forecasted Market Size by Region (2026-2031)

2.3 Age-related Macular Degeneration Drugs Market Dynamics

2.3.1 Age-related Macular Degeneration Drugs Industry Trends

2.3.2 Age-related Macular Degeneration Drugs Market Drivers

2.3.3 Age-related Macular Degeneration Drugs Market Challenges

2.3.4 Age-related Macular Degeneration Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Age-related Macular Degeneration Drugs Players by Revenue

3.1.1 Global Top Age-related Macular Degeneration Drugs Players by Revenue (2020-2025)

3.1.2 Global Age-related Macular Degeneration Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Top Age-related Macular Degeneration Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Age-related Macular Degeneration Drugs Revenue

3.4 Global Age-related Macular Degeneration Drugs Market Concentration Ratio

3.4.1 Global Age-related Macular Degeneration Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Drugs Revenue in 2024

3.5 Global Key Players of Age-related Macular Degeneration Drugs Head office and Area Served

3.6 Global Key Players of Age-related Macular Degeneration Drugs, Product and Application

3.7 Global Key Players of Age-related Macular Degeneration Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Age-related Macular Degeneration Drugs Breakdown Data by Type

4.1 Global Age-related Macular Degeneration Drugs Historic Market Size by Type (2020-2025)

4.2 Global Age-related Macular Degeneration Drugs Forecasted Market Size by Type (2026-2031)

5 Age-related Macular Degeneration Drugs Breakdown Data by Application

5.1 Global Age-related Macular Degeneration Drugs Historic Market Size by Application (2020-2025)

5.2 Global Age-related Macular Degeneration Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Age-related Macular Degeneration Drugs Market Size (2020-2031)

6.2 North America Age-related Macular Degeneration Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Age-related Macular Degeneration Drugs Market Size by Country (2020-2025)

6.4 North America Age-related Macular Degeneration Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Age-related Macular Degeneration Drugs Market Size (2020-2031)

7.2 Europe Age-related Macular Degeneration Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Age-related Macular Degeneration Drugs Market Size by Country (2020-2025)

7.4 Europe Age-related Macular Degeneration Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Age-related Macular Degeneration Drugs Market Size (2020-2031)

8.2 Asia-Pacific Age-related Macular Degeneration Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Age-related Macular Degeneration Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Age-related Macular Degeneration Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Age-related Macular Degeneration Drugs Market Size (2020-2031)

9.2 Latin America Age-related Macular Degeneration Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Age-related Macular Degeneration Drugs Market Size by Country (2020-2025)

9.4 Latin America Age-related Macular Degeneration Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Age-related Macular Degeneration Drugs Market Size (2020-2031)

10.2 Middle East & Africa Age-related Macular Degeneration Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Age-related Macular Degeneration Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Age-related Macular Degeneration Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Regeneron Pharmaceuticals

11.1.1 Regeneron Pharmaceuticals Company Details

11.1.2 Regeneron Pharmaceuticals Business Overview

11.1.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Drugs Introduction

11.1.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.1.5 Regeneron Pharmaceuticals Recent Development

11.2 Roche Holding

11.2.1 Roche Holding Company Details

11.2.2 Roche Holding Business Overview

11.2.3 Roche Holding Age-related Macular Degeneration Drugs Introduction

11.2.4 Roche Holding Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.2.5 Roche Holding Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Age-related Macular Degeneration Drugs Introduction

11.3.4 Novartis Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Age-related Macular Degeneration Drugs Introduction

11.4.4 Bayer Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Biogen

11.5.1 Biogen Company Details

11.5.2 Biogen Business Overview

11.5.3 Biogen Age-related Macular Degeneration Drugs Introduction

11.5.4 Biogen Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.5.5 Biogen Recent Development

11.6 Alimera Sciences

11.6.1 Alimera Sciences Company Details

11.6.2 Alimera Sciences Business Overview

11.6.3 Alimera Sciences Age-related Macular Degeneration Drugs Introduction

11.6.4 Alimera Sciences Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.6.5 Alimera Sciences Recent Development

11.7 Adverum Biotechnologies

11.7.1 Adverum Biotechnologies Company Details

11.7.2 Adverum Biotechnologies Business Overview

11.7.3 Adverum Biotechnologies Age-related Macular Degeneration Drugs Introduction

11.7.4 Adverum Biotechnologies Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.7.5 Adverum Biotechnologies Recent Development

11.8 Eyepoint Pharmaceuticals

11.8.1 Eyepoint Pharmaceuticals Company Details

11.8.2 Eyepoint Pharmaceuticals Business Overview

11.8.3 Eyepoint Pharmaceuticals Age-related Macular Degeneration Drugs Introduction

11.8.4 Eyepoint Pharmaceuticals Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.8.5 Eyepoint Pharmaceuticals Recent Development

11.9 Outlook Therapeutics

11.9.1 Outlook Therapeutics Company Details

11.9.2 Outlook Therapeutics Business Overview

11.9.3 Outlook Therapeutics Age-related Macular Degeneration Drugs Introduction

11.9.4 Outlook Therapeutics Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.9.5 Outlook Therapeutics Recent Development

11.10 Apellis Pharmaceuticals

11.10.1 Apellis Pharmaceuticals Company Details

11.10.2 Apellis Pharmaceuticals Business Overview

11.10.3 Apellis Pharmaceuticals Age-related Macular Degeneration Drugs Introduction

11.10.4 Apellis Pharmaceuticals Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.10.5 Apellis Pharmaceuticals Recent Development

11.11 Amgen

11.11.1 Amgen Company Details

11.11.2 Amgen Business Overview

11.11.3 Amgen Age-related Macular Degeneration Drugs Introduction

11.11.4 Amgen Revenue in Age-related Macular Degeneration Drugs Business (2020-2025)

11.11.5 Amgen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Regeneron Pharmaceuticals

Roche Holding

Bayer

Biogen

Alimera Sciences

Adverum Biotechnologies

Eyepoint Pharmaceuticals

Outlook Therapeutics

Apellis Pharmaceuticals

Amgen Inc

List of Tables

Table 1. Global Age-related Macular Degeneration Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antioxidants

Table 3. Key Players of Anti-inflammatory Drugs

Table 4. Key Players of Others

Table 5. Global Age-related Macular Degeneration Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Age-related Macular Degeneration Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Age-related Macular Degeneration Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Age-related Macular Degeneration Drugs Market Share by Region (2020-2025)

Table 9. Global Age-related Macular Degeneration Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Age-related Macular Degeneration Drugs Market Share by Region (2026-2031)

Table 11. Age-related Macular Degeneration Drugs Market Trends

Table 12. Age-related Macular Degeneration Drugs Market Drivers

Table 13. Age-related Macular Degeneration Drugs Market Challenges

Table 14. Age-related Macular Degeneration Drugs Market Restraints

Table 15. Global Age-related Macular Degeneration Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Age-related Macular Degeneration Drugs Market Share by Players (2020-2025)

Table 17. Global Top Age-related Macular Degeneration Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration Drugs as of 2024)

Table 18. Ranking of Global Top Age-related Macular Degeneration Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Age-related Macular Degeneration Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Age-related Macular Degeneration Drugs, Headquarters and Area Served

Table 21. Global Key Players of Age-related Macular Degeneration Drugs, Product and Application

Table 22. Global Key Players of Age-related Macular Degeneration Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Age-related Macular Degeneration Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Age-related Macular Degeneration Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Age-related Macular Degeneration Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Age-related Macular Degeneration Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Age-related Macular Degeneration Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Age-related Macular Degeneration Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Age-related Macular Degeneration Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Age-related Macular Degeneration Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Age-related Macular Degeneration Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Age-related Macular Degeneration Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Age-related Macular Degeneration Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Age-related Macular Degeneration Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Age-related Macular Degeneration Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Age-related Macular Degeneration Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Age-related Macular Degeneration Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Age-related Macular Degeneration Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Age-related Macular Degeneration Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Age-related Macular Degeneration Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Age-related Macular Degeneration Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Age-related Macular Degeneration Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Age-related Macular Degeneration Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Age-related Macular Degeneration Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Age-related Macular Degeneration Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Regeneron Pharmaceuticals Company Details

Table 48. Regeneron Pharmaceuticals Business Overview

Table 49. Regeneron Pharmaceuticals Age-related Macular Degeneration Drugs Product

Table 50. Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 51. Regeneron Pharmaceuticals Recent Development

Table 52. Roche Holding Company Details

Table 53. Roche Holding Business Overview

Table 54. Roche Holding Age-related Macular Degeneration Drugs Product

Table 55. Roche Holding Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 56. Roche Holding Recent Development

Table 57. Novartis Company Details

Table 58. Novartis Business Overview

Table 59. Novartis Age-related Macular Degeneration Drugs Product

Table 60. Novartis Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Bayer Company Details

Table 63. Bayer Business Overview

Table 64. Bayer Age-related Macular Degeneration Drugs Product

Table 65. Bayer Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 66. Bayer Recent Development

Table 67. Biogen Company Details

Table 68. Biogen Business Overview

Table 69. Biogen Age-related Macular Degeneration Drugs Product

Table 70. Biogen Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 71. Biogen Recent Development

Table 72. Alimera Sciences Company Details

Table 73. Alimera Sciences Business Overview

Table 74. Alimera Sciences Age-related Macular Degeneration Drugs Product

Table 75. Alimera Sciences Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 76. Alimera Sciences Recent Development

Table 77. Adverum Biotechnologies Company Details

Table 78. Adverum Biotechnologies Business Overview

Table 79. Adverum Biotechnologies Age-related Macular Degeneration Drugs Product

Table 80. Adverum Biotechnologies Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 81. Adverum Biotechnologies Recent Development

Table 82. Eyepoint Pharmaceuticals Company Details

Table 83. Eyepoint Pharmaceuticals Business Overview

Table 84. Eyepoint Pharmaceuticals Age-related Macular Degeneration Drugs Product

Table 85. Eyepoint Pharmaceuticals Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 86. Eyepoint Pharmaceuticals Recent Development

Table 87. Outlook Therapeutics Company Details

Table 88. Outlook Therapeutics Business Overview

Table 89. Outlook Therapeutics Age-related Macular Degeneration Drugs Product

Table 90. Outlook Therapeutics Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 91. Outlook Therapeutics Recent Development

Table 92. Apellis Pharmaceuticals Company Details

Table 93. Apellis Pharmaceuticals Business Overview

Table 94. Apellis Pharmaceuticals Age-related Macular Degeneration Drugs Product

Table 95. Apellis Pharmaceuticals Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 96. Apellis Pharmaceuticals Recent Development

Table 97. Amgen Company Details

Table 98. Amgen Business Overview

Table 99. Amgen Age-related Macular Degeneration Drugs Product

Table 100. Amgen Revenue in Age-related Macular Degeneration Drugs Business (2020-2025) & (US$ Million)

Table 101. Amgen Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Age-related Macular Degeneration Drugs Picture

Figure 2. Global Age-related Macular Degeneration Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Age-related Macular Degeneration Drugs Market Share by Type: 2024 VS 2031

Figure 4. Antioxidants Features

Figure 5. Anti-inflammatory Drugs Features

Figure 6. Others Features

Figure 7. Global Age-related Macular Degeneration Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Age-related Macular Degeneration Drugs Market Share by Application: 2024 VS 2031

Figure 9. Wet AMD Treatment Case Studies

Figure 10. Adjunctive Treatment of Dry AMD Case Studies

Figure 11. Others Case Studies

Figure 12. Age-related Macular Degeneration Drugs Report Years Considered

Figure 13. Global Age-related Macular Degeneration Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Age-related Macular Degeneration Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Age-related Macular Degeneration Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Age-related Macular Degeneration Drugs Market Share by Players in 2024

Figure 17. Global Age-related Macular Degeneration Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Drugs Revenue in 2024

Figure 19. North America Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Age-related Macular Degeneration Drugs Market Share by Country (2020-2031)

Figure 21. United States Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Age-related Macular Degeneration Drugs Market Share by Country (2020-2031)

Figure 25. Germany Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Age-related Macular Degeneration Drugs Market Share by Region (2020-2031)

Figure 33. China Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Age-related Macular Degeneration Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Age-related Macular Degeneration Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Age-related Macular Degeneration Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Regeneron Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 49. Roche Holding Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 51. Bayer Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 52. Biogen Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 53. Alimera Sciences Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 54. Adverum Biotechnologies Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 55. Eyepoint Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 56. Outlook Therapeutics Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 57. Apellis Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 58. Amgen Revenue Growth Rate in Age-related Macular Degeneration Drugs Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Global Anti VEGF Ophthalmic Drugs Market Research Report 2024

Global Anti VEGF Drugs for the Treatment of Wet AMD Market Research Report 2024

Global Anti VEGF Intravitreal Drugs Market Research Report 2024

Global Ranibizumab Injection Market Research Report 2024

Global Macular Degeneration Treatment Market Research Report 2024

Global Ophthalmology for Age related Macular Degeneration Diseases Market Research Report 2024

Global Geographic Atrophy Drugs Market Research Report 2024

Global VEGF A Inhibitor Market Research Report 2024

Global Macular Edema and Macular Degeneration Market Research Report 2025

Global Medical Grade Anti Aging Drugs Market Research Report 2024

Global Single target Anti VEGF Drugs Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions